CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,180 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 19,575 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 19,575 shares (grant or award)
- 4 Grant or award Director acquired 10,180 shares (grant or award)
- 4 Shares withheld for taxes EVP, Commercial gave up 11,723 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 8,444 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Scientific Strategy & CSO gave up 6,123 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 5,349 shares (to pay taxes)
- 4 Open-market sale Director sold 40,000 shares at $19.65 ($786,000)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Director sold 6,696 shares at $23.00 ($154,008)
- 4 Open-market sale EVP, Commercial sold 20,000 shares at an average $22.72 ($454,300)
- 4 Open-market sale EVP, General Counsel & Sec sold 18,000 shares at $22.00 ($396,000)
- 4 Grant or award President and CEO acquired 270,415 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 75,985 shares (grant or award)
Page 14 of 73 · 1,458 filings